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Nine partially halogenated benzylphosphanes ArXCH2PR2 (ArX = 3,6-dichlorophenyl, 3,6-43 
difluorophenyl and 3,4,5-trifluorophenyl; R = Ph, Cy, iPr) have been prepared and reacted with 44 
palladium acetate to obtain the cyclometallated dimers [Pd(μ-OAc)(κ2-C,P-ArXCH2PR2)]2. The 45 
acetate bridge has been exchanged by bromide using lithium bromide and the obtained dimers have been 46 
thoroughly characterised. The dimers with the non-halogenated phosphanes PhCH2PR2 (R = Ph, iPr) 47 
have also been prepared. Treatment with norbornadiene in the presence of silver tetrafluoroborate has 48 
furnished the cationic mononuclear complexes [Pd(κ2-C,P-ArXCH2PR2)(nbd)]BF4 as stable solids. 49 
These complexes and some of the bromide dimers have been used as catalytic precursors in the 50 
Mizoroki- Heck reaction between bromobenzene and butyl acrylate. The complexes efficiently catalyse 51 
this transformation and important differences of activity are found depending on the ligand. In general, 52 




In 2010, Richard F. Heck, Ei-ichi Negishi and Akira Suzuki were awarded with the Nobel Prize in 57 
Chemistry “for palladium-catalyzed cross couplings in organic synthesis”. The currently known as 58 
Mizoroki-Heck, Negishi and Suzuki–Miyaura reactions revolutionised the field of organic synthesis by 59 
allowing the formation of C–C bonds under mild conditions.[1] The three reactions are efficiently 60 
catalysed by Pd(0) species and have been used to prepare countless molecules of industrial or 61 
pharmacological interest and remain central in the synthetic toolkit. The Mizoroki-Heck [M – H] 62 
reaction is the coupling between an aryl halide or tosylate with an alkene, catalysed by Pd(0) in the 63 
presence of a base (Scheme 1).[2] 64 
 65 
Compared to the Negishi or the Suzuki–Miyaura couplings, the M–H reaction is particular 66 
because: 1) was the first to be discovered and paved the way to the discovery of the other cross-coupling 67 
reactions; 2) it is mechanistically distinct compared to the other cross-coupling reactions and 3) uses 68 
cheap and widely available unfunctionalised alkenes as coupling partners. The last reason is particularly 69 
important and explains the intense interest in the M–H reaction in both academia and industry, a 70 
research effort that has given tens of thousands of publications and patents and has been collected in 71 
many reviews.[3] The generally accepted mechanism of the M–H reaction involves a Pd(0)/Pd(II) 72 
catalytic cycle[3d,3h] although usually the more stable Pd(II) systems are used as precatalysts. Simple 73 
palladium(II) salts such as palladium acetate or chloride,[2b,4] molecular complexes and 74 
organometallics[3b,5] as well as heterogeneous catalysts or “heterogenized” molecular species[6] have 75 
been used in the M–H reaction. Among the many systems studied, Herrmann's[4a,5,7] cyclometallated 76 
dimeric complexes with phosphanes (Figure 1) were found to produce exceptionally active systems for 77 
the reaction[8] and remain a landmark in the area. 78 
 79 
These systems were discovered when exploring the use of o-tolylphosphanes in M–H reactions, 80 
with palladium acetate as metallic precursor. Under catalytic conditions the methyl group of the o-tolyl 81 
substituent is activated forming the dimeric Herr mann's catalyst, with acetate bridges. Inspired by these 82 
results, a few years later Cole–Hamilton and co-workers[9] reported metallated complexes of palladium 83 
with simple benzylphosphanes (Figure 1), which were also found to be very active in M–H reactions and 84 
also in Suzuki–Miyaura couplings. Cyclopalladated compounds with benzylphosphanes have indeed a 85 
long history. As early as 1975 Shaw and co-workers[10] showed that complexes trans-[PdCl2L2] (L = 86 
PBn2 (tBu) and PBn(tBu2)2) undergo internal metallation, with certain difficulty, to give complexes of 87 
the type [Pd(μ-Cl)(κ2-C,P-PBnRR′)]2. It was found that the bulkier PBn(tBu2)2 is metallated more 88 
readily than PBn2(tBu). The bridging chlorides could be replaced by bromide or iodide and the bridges 89 
split by various ligands to give mononuclear species. A few years later, Vrieze and coworkers[11] 90 
reacted PBnR2 (R = Cy, tBu) with [Rh(cod)Cl]2, [Ir(cod)Cl]2, PdCl2 and PtCl2(benzonitrile)2, 91 
obtaining the corresponding cyclometallated compounds. It was found that steric effects have a large 92 
influence on the rates of the reactions. Hiraki and co-workers[12] were the first to cyclopalladate 93 
benzyldiphenylphosphane with palladium acetate, giving the dimeric acetate-bridged complex, which 94 
could be converted into the corresponding chloro-bridged analogue by a metathesis reaction with lithium 95 
chloride. Much more recently, Leung and coworkers[13] demonstrated that steric shielding greatly 96 
favours the palladation of benzylphosphanes and found that bis(tertbutyl)(diphenylmethyl)phosphane 97 
readily palladates even under conditions known to disfavour the reaction. Interestingly, Gatineau et 98 
al.[14] explored the cyclometallation of PBn(tBu)-(o-tolyl) with palladium acetate and found that the o-99 
tolyl group not the benzyl, was palladated, proving that often C(sp3)–H bonds are activated more easily 100 
than C(sp2)-H. We reasoned that modification of the Cole–Hamilton systems by introduction of halogen 101 
atoms in the ortho-metallated benzyl substituent would result in stronger Pd–Caryl bonds and could give 102 
more robust catalysts. In addition, we also envisaged the preparation of mononuclear, cationic versions 103 
of the Cole-Hamilton's catalysts, stabilised by a norbornadiene to obtain more active catalysts, since the 104 
dimeric systems are thought to give mononuclear complexes under catalytic conditions. The results on 105 
the synthesis and characterisation of the polyhalogenated phosphanes and their derived cyclopalladated 106 
compounds and the applications of the complexes in the M–H reaction are described in this paper. 107 
108 
RESULTS AND DISCUSSION 109 
 110 
The cyclometallated dimers of Cole–Hamilton and co-workers[9] (Figure 1) were obtained by 111 
oxidative addition of o-bromobenzylphosphanes with the Pd(0) precursor [Pd2(dba)3]. Although very 112 
efficient, this method requires a bromo substituent to be installed in the benzylphosphane, which would 113 
make the synthesis of the desired polyhalogenated phosphanes rather difficult. Therefore, the direct 114 
palladation of the polyhalogenated benzylphosphanes by C–H activation with palladium acetate was 115 




The synthesis of di- and trihalogenated benzylphosphanes was explored by two methods (Scheme 120 
2): the alkylation of secondary phosphanes with benzyl bromides in the presence of base (A)[15] and the 121 
treatment of chlorophosphanes with benzylic Grignard reagents (B). 122 
 123 
Although both methods allowed the synthesis of the desired ligands, method B provided slightly 124 
higher yields and much better reproducibility and therefore was selected as default. As the free 125 
phosphanes turned out to be very air-sensitive, they were immediately either coordinated or protected 126 
with borane for storage and complete characterisation. For comparison purposes, non-halogenated 127 
phosphanes benzyldiphenylphosphane (4a) and benzyldiisopropylphosphane (4c) were also considered. 128 
Phosphane 4a is commercially available while 4c was prepared by method B employing commercially 129 
available benzylmagnesium chloride solution and following a literature procedure.[16] The free 130 
phosphanes were characterised by 31P{1H} NMR spectroscopy while their borane adducts were 131 
characterised by 31P{1H}, 1H and 13C{1H} NMR spectroscopy, IR spectroscopy, mass spectrometry 132 
and chemical analysis. The most relevant NMR data is given in Table 1. As expected, 31P chemical 133 
shifts strongly depended on the identity of the phosphane groups, with only a minor influence of the 134 
substitution in benzyl group. Diphenylphosphanes (a) appeared at the highest field followed by 135 
dicyclohexylphosphanes (b) and finally diisopropylphoshines (c). It was possible to grow crystals of 136 
phosphane-boranes 2a′ and 3c′ by slow diffusion of ethanol into concentrated dichloromethane solutions 137 
of the corresponding phosphane-boranes, at 4 °C. The molecular structures are shown in Figure 2 along 138 
with a selection of bond lengths and angles. 139 
 140 
No significant differences in bond lengths and angles were found for adducts 2c′ and 3c′, which 141 




Neutral Palladium Complexes 146 
 147 
In the present work, with the aim of obtaining cyclometallated complexes the reaction of 148 
benzylphosphanes and palladium acetate was studied in detail in toluene due to increased stability of 149 
phosphanes in this solvent. Palladium acetate has been known to be particularly effective to palladate 150 
phosphanes.[12,14,20] When the reaction was performed at room temperature, palladium coordination 151 
complexes ([Pd(OAc)nP2]) were obtained and could be unequivocally identified upon conversion to 152 
trans-[PdBr2P2] by treatment with lithium bromide in acetone. An increase of the temperature was 153 
necessary to observe the C(sp2)-H activation of the benzyl substituent of the phosphane. From 154 
temperatures in the range 50–60 °C it was already possible to detect cyclometallated complexes. The 155 
addition of a base like NaOAc was convenient to favour the C–H activation and improve the yield of the 156 
palladium dimer and the reproducibility of the reaction.  157 
Palladium dimers [Pd(μ-OAc)(κ2-PC)]2 (6c, 7b, 8a) containing the desired five-membered PdPC 158 
ring were obtained at 60 °C in 12 h while heating at 80 °C allowed the formation of the cyclometallated 159 
dimers for all the phosphanes (Scheme 3).  160 
The cyclopalladation of the benzylic phosphanes could be monitored by 31P{1H} NMR 161 
spectroscopy. In all cases different amounts (10–30 %) of coordination compounds [Pd(OAc)nP2] were 162 
also detected as well as small amounts of starting palladium acetate and palladium black. The reaction 163 
mixture containing the palladium dimer was filtered through celite and the crude toluene solution was 164 
evaporated to dryness. The reaction of the solid residue with LiBr in acetone at room temperature for 165 
two hours led to the substitution of the acetate bridge and to the formation of the dimeric compounds 166 
[{Pd(κ2-PC)}(μ-Br)]2 (8, 9, 10 and 12).[8b,12,14,20] In some occasions the coordination compound 167 
trans-[PdBr2P2] was also obtained and was separated by precipitation or column chromatography. 168 
In some cases, like with phosphane 2b or if the reaction was carried out without adding sodium acetate, 169 
the formation of other compounds was observed (Scheme 4). 170 
In this case the reaction of 2b with palladium acetate yields the expected dimer 6b but also the 171 
monomeric species 6b′ resulting from the splitting of this dimer with another equivalent of 2b and the 172 
coordination compound [Pd(2b)2(OAc)2]. The ratio between the three species was 1.0:0.7:0.5 173 
approximately. It could be observed that when mixtures of the metallated dimers and the corresponding 174 
coordination compounds [Pd(PR2CH2ArX)2(OAc)2] are left at 80 °C in the presence of Figure 3. 175 
31P{1H} NMR spectrum of a mixture of brominated complexes obtained from 2b. Eur. J. Inorg. Chem. 176 
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acetate for long periods of time, the monomeric complexes [PdBr((κ2-PC)(PR3)]] and unidentified 178 
decomposition products are obtained. 31P{1H} NMR spectroscopy was an invaluable tool to analyse 179 
this kind of mixtures. As an example, Figure 3 shows the 31P{1H} NMR spectrum of complexes of 180 
Scheme 4. 181 
Complexes 10 showed low solubility in common organic solvents such as dichloromethane, 182 
toluene or THF and all are stable as solids under nitrogen atmosphere. The new palladium complexes 183 
obtained [Pd(κ2-PC)(μ-Br)]2 (8, 9, 10, 11 and 12) were characterized by elemental analysis, infrared 184 
spectroscopy and multi-nuclear (31P{1H}, 1H, 19F and 13C{1H}) NMR spectroscopy. The metallated 185 
dimers with acetate bridge showed broad signals in both the 31P{1H} and 1H NMR spectra, in 186 
particular those with the diphenylphoshino group (a) and only the 31P{1H} spectra are presented. This 187 
is due to the fluxional character of the compounds and to the possible existence of an equilibrium 188 
between the monomer and the dimer, owing to the weakly bound acetate anions.[5] Relevant NMR data 189 
is summarized in Table 2. 190 
As expected, 13P{1H} NMR spectra showed a shift towards lower fields in all the complexes 191 
with respect to free phosphane. The ring contribution effect[21] is very important as reflected for 192 
example in the spectrum of complex 9b′ (Table 3) with the same phosphane in the cyclometallated 193 
compound (δ = +71.5 ppm) and as simply P-coordinated ligand (δ = +28.4 ppm). The shift values 194 
followed the order –PiPr2 (c) > –PCy2 (b) > –PPh2 (a) for each benzyl group, and the sequence –2,5-195 
F2Ph > –Ph > –3,4,5-F3Ph > –2,5-Cl2Ph for each –PR2 moiety. Furthermore, the mixture of the two 196 
possible isomers (cis and trans) was observed in the acetate bridge complexes 5b, 6a and 7a, and in the 197 
bromide bridge for complexes 9a, 10a, 12a and 12c. 198 
19F{1H}, 13C{1H} and 1H NMR spectra of 5–12 showed less significant variations when 199 
forming the metallacycles. The values of the signals of the complexes bearing –PiPr2 and –PCy2 200 
moieties are similar, in accordance with their comparable steric and electronic characteristics. It is 201 
interesting to note that the methyl groups of the isopropyl moiety in complexes derived from phosphanes 202 
c are not equivalent and appear as doublet of doublet sets. 203 
Free phosphanes 2 containing the difluorobenzyl group showed a 4JPF of about 10 Hz, however 204 
in the dimeric palladacycles 5 and 8 this coupling was not observed at the same 101.1 MHz field. 205 
However, in the case of mononuclear complexes 6b′ and 9b′ (Table 3) the coupling constant reappears at 206 
the coordinated phosphane with values around 30 Hz, but here there are two fluorine atoms in the same 207 
four bonds range 4JPF. In order to ascertain the origin of the P–F coupling the splitting of the dinuclear 208 
complex 9c with PCy3 was performed to obtain complex 13c (Scheme 5). 209 
To a toluene solution of 9c a slight excess of tricyclohexylphosphane was added at room 210 
temperature, the complete splitting of the dimer was observed by 31P{1H} NMR after one hour of 211 
reaction. The neutral compound 13c was readily obtained and characterized by standard methods. The 212 
spectra were obtained in CDCl3 and it showed small amounts of the product of the Pd-Br/Cl halogen 213 
exchange, leading to the duplication of signals both in the 1H and 31P{1H} NMR. The 31P{1H} NMR  214 
The 31P{1H} NMR signals are consistent with the presence of only the trans isomer (2JPP = 215 
414.0 Hz) of 13c. Furthermore, the coupling between the phosphorus atom of the PCy3 and the fluorine 216 
atom in ortho position of the phenyl ligand was observed (4JPF = 27.4 Hz). This means that the 4JPF 217 
observed in the mononuclear complexes 6b′ and 9b′ in the signal of the monodentate phosphane could 218 
be assigned to the same coupling with the fluorine in ortho position of the phenyl ligand. The exclusive 219 
formation of the trans isomer can be justified on steric arguments although electronic factors could also 220 
play a role.[22] 221 
Despite many attempts, single crystals suitable for X-ray diffraction could not be obtained for any 222 
of complexes with the halogenated phosphanes. Fortunately, single crystals could be obtained for dimers 223 
12a and 12c, containing the simple benzylphosphanes 4a and 4c respectively. The structures of the 224 
dimers are shown in Figure 4. 225 
The structures contain the expected dimeric complexes with square-planar geometries around the 226 
Pd atoms. Both structures correspond to the transoid isomers and have a crystallographic inversion 227 
centre and hence the {Pd2Cl2} moiety is completely flat. The cyclometallation forces a much smaller P–228 
Pd–C1 angle compared to the others around the metal centre. Interestingly, coordination bonds of 12a 229 
are slightly shorter than those of 12c, probably due to less steric requirements of 4a compared to 4c. 230 
Rather surprisingly, the structures of 12a and 12c are the first to be reported for bromo-bridged dimers 231 
with cyclometallated benzylphosphanes. Indeed, there are only a few structures of chloro-bridge 232 
dimers,[20,23] including chloro-analogue of 12a, described by Smoliakova and co-workers.[23] The 233 
parameters of 12a and 12b are similar to those reported structures except the Pd–Br distances which as 234 
expected are longer than the Pd–Cl. 235 
 236 
 237 
Ionic Palladium Complexes 238 
 239 
Reaction of a dichloromethane solution of the palladium dimers 8c, 9c, 10a–c, 12a and 12c (1 240 
equiv.) with a slight excess of norbornadiene and silver tetrafluoroborate (3 equiv.) afforded the ionic 241 
palladium complexes of general formulae [Pd(κ2-PC)-(norbornadiene)]BF4 (Scheme 6). The new 242 
compounds were obtained as pure solids after separation of the silver bromide by filtration through a 243 
celite pad.  244 
The ionic complexes were characterized by elemental analysis, infrared spectroscopy and multi-245 
nuclear NMR spectroscopy. There are no significant changes in the NMR of the metallacycle (Table 4 246 
and Figure 5).  247 
Interestingly, the 1H NMR spectra shows the splitting of the signal of the methylene group of the 248 
norbornadiene ligand. In addition, the signals of the olefinic protons differ markedly due to the distinct 249 
ligands in trans position, phosphorus or carbon. The contacts observed in the NOESY spectrum of 15c 250 
(Figure 5) allowed to assign the signal at lower fields to the double bond trans to the phosphorus atom. 251 
The molecular structure of 17a could be obtained by X-ray diffraction methods and it is 252 
represented in Figure 6.  253 
 254 
The molecular structure confirms the identity of 17a as a mononuclear complex with the Pd atom 255 
containing the cyclometallated ligand 4a and a norbornadiene coordinated by the two double bonds. The 256 
distances between the Pd atom and 4a are slightly longer than in 12a and the norbornadiene ligand is 257 
coordinated in slightly asymmetric fashion because the C1–C2  bond is closer to the Pd than the C6–C7 258 
bond. To the best of our knowledge, the structure of 17a is the first one ever reported to contain a 259 
palladium coordinated to a metallated phosphane and a diene. In the reported structures of 260 
[PdCl2(nbd)][24] and [PdBr2(nbd)][25] the distances between the Pd and the diene are considerably 261 
shorter. In contrast, other structures containing the palladium embedded in a palladacyclopentadiene[26] 262 
present similar Pd–nbd distances than in 17a. This suggests that the cyclometallated phosphane exerts a 263 






To test the performance of the cyclopalladated compounds, the M–H reaction between 270 
bromobenzene and butyl acrylate (Scheme 7) was chosen. 271 
 272 
The palladium complexes 9c and 15c, containing the same phosphane ligand 2c, were selected to 273 
establish the optimal reaction conditions. In order to study the stability of these complexes, some 274 
melting point determinations were carried out, but decomposition was found instead. The fluorinated 275 
neutral dimeric complex 9c decomposed to palladium black at approximately 225 °C while the cationic 276 
counterpart 15c did the same at 165 °C. For the non-fluorinated complexes 12a and 17a, 277 
thedecomposition temperatures were approximately 215 and 160 °C respectively. 278 
The initial catalytic experiments were carried out with 15c and sodium acetate as base. The ratio 279 
Pd/PhBr/butyl acrylate was set to 1:1000:1500 (0.1 % catalyst loading) while the PhBr/NaOAc ratio was 280 
set to 1:1.1. Under these conditions, no formation of the M–H product was observed at 80 °C, and the 281 
temperature was gradually increased in intervals of 10 °C until at 120 °C some product could be 282 
detected after 1 h of reaction time. Therefore, a compromise temperature of 130 °C was selected because 283 
it was high enough to have an active system, but well below the decomposition temperature of the 284 
complexes. In the literature, temperatures in the range 115–165 °C are commonly used in M–H reactions 285 
using cyclopalladated compounds as catalytic precursors.[27] 286 
Under these conditions, N,N-dicyclohexylmethylamine, sodium acetate and caesium carbonate 287 
were tested as a base. After 20 h, the conversions using precursor 15c were 3, 13 and 80 % respectively 288 
so caesium carbonate was selected as by default base. 289 
Then the effect of the amount of catalytic precursor was studied. When the relative amount of the 290 
palladium complex  (15c) was duplicated to 0.2 % (Pd/PhBr/butyl acrylate = 2:1000:1500), the rate of 291 
the reaction decreased, achieving a TOF value of 70 h–1 at 1 h, compared to 260 h–1 with 292 
Pd/PhBr/butyl acrylate = 1:1000:1500. The rate reduction is significant because with 0.1 % catalyst 293 
loading, the 50 % conversion time was attained after approximately 3 h, while doubling the loading of 294 
the precatalyst delayed this time until 4 h. For this reason, the catalyst loading was set to 0.1 %. The use 295 
of an excess of olefin was also detrimental on the rate because with a Pd/PhBr/butyl acrylate = 296 
1:1000:3000 the TOF was 110 h–1. It seems, therefore, that the activity does not depend on the total 297 
amount of palladium. Evolution of the catalytic precursor to colloidal Pd(0) species could justify this 298 
behavior.[27,28] 299 
The effect of the concentration was also studied. Halving the concentration from 0.67 to 0.38 M 300 
led to similar conversions and TOF values. However, the reproducibility of the reaction was better at 301 
higher dilution, probably because the formation of palladium agglomerates is less favoured. 302 
The cationic complex 15c showed a higher initial activity at 1 h (TOF = 260 h–1) than the neutral 303 
dimer 9c (TOF = 180 h–1) but at longer reaction times both precursors led to the same results. This may 304 
indicate the opening of dimer 9c forming active, mononuclear species over time. 305 
After having optimised the reaction conditions, we performed the systematic screening of the 306 
cyclometallated complexes in the M–H reaction between bromobenzene and butyl acrylate (Table 5). 307 
The conversions and selectivities (which were found to be > 95 % towards the M–H product) 308 
were determined by GC. In a few cases, Pd black could be observed in the reaction flasks after the 309 
consumption of the reagents. It was found that the precursors were active, giving good conversions in 310 
most cases towards the M–H product after 6 h of reaction time. There were, however, important 311 
differences in reaction rates depending on the phosphane substituents, especially at 1 h reaction times. 312 
There is not a clear trend when comparing the performance between monomeric and dimeric precursors 313 
with the same ligand. In the case of ligand 2c (entries 1 and 5) and 4a (entries 2 and 7) the differences 314 
are relatively minor suggesting the formation of the same mononuclear catalytically active species from 315 
dimers.[29] In contrast, monomeric complex 16c (entry 6) unexpectedly gives very low conversions and 316 
TOFs regardless of the reaction time while its dimeric counterpart 12c (entry 3) is one of the most 317 
active. These differences show that the ligand influences the active species formed under catalytic 318 
conditions. It seems that sometimes the monomeric and dimeric complexes lead to the same catalytically 319 
active species and sometimes not, or less efficiently. 320 
In some cases, the activity of the precursors increases with the electronegativity of the substituents of the 321 
cyclometallated aryl ring. This can be clearly seen comparing entries 6 (2H in the aryl) 4 (2Cl) and 5 322 
(2F) and may be due to the stronger Caryl–Pd bond in halogenated phosphanes, as originally reasoned 323 
when the halogenated benzylphosphanes were designed. This is however not general: ligand 3c (entry 324 
10) gives a less active system than ligand 2c (entry 5) despite the former having a trifluorinated aryl ring 325 
compared to a difluorinated ring for the latter.  326 
For the trifluorinated aryl ring it is found that the diphenylphosphanes produce less active 327 
precursors compared to diisopropyl or dicyclohexylphosphanes (entries 8–10), but in contrast the most 328 
active system overall, 17a (entry 7) is the simple benzyldiphenylphosphane, in accordance with the 329 
results of Cole–Hamilton and co-workers.[9] With precursor 15c the M–H with styrene was also tested 330 
(entry 11) giving very similar results than with butyl acrylate (entry 5). 331 
In order to explore the usefulness of catalysts based on halogenated phosphanes in the M–H of 332 
other aryl bromides, a few experiments were also carried out with the reaction of butyl acrylate with 333 
electron-poor 4-bromobenzaldehyde and with electron-rich 4-bromoanisol (Table 6). 334 
As expected, the reactions with 4-bromobenzaldehyde (entries 1–3) proceeded much faster than 335 
with bromobenzene, due to the weaker nature of the C–Br bond, which favours oxidative addition to 336 
Pd(0). In spite of this, the tendencies with this substrate were the same as those observed in Table 5. 337 
Unsurprisingly, 4-bromoanisol (entry 4) was a poorer substrate than bromobenzene (Table 5, entry 5) 338 




This paper has described the systematic preparation of new benzylphosphanes partially 343 
halogenated at the phenyl group, showing that the reaction of benzylmagnesium reagents with 344 
chlorophosphanes is the best method to prepare such compounds. The tendency of benzylphosphanes to 345 
form cyclopalladated compounds has been used to prepare acetate-bridged and bromide-bridged 346 
complexes as pure stable solids. Bromide scavenging by silver tetrafluoroborate has allowed the 347 
obtention of cationic, nbd-stabilised mononuclear complexes. The use of 0.1 % loading of palladium 348 
complexes in the Mizoroki- Heck reaction between bromobenzene and butyl acrylate has provided good 349 
conversions after a few hours for several systems. The results are in the same range that those obtained 350 
by other palladacycles[27,30] under similar conditions and confirm that cyclopalladated complexes are 351 
an excellent choice for M–H reactions.[5,8a,8c,31] 352 
Although the original idea that halogenated benzylphosphanes would give cyclopalladated 353 
compounds with stronger Pd–Caryl bonds and hence more robust and active precursors has been 354 
observed in a few cases, in general the halogenated precursors have not provided better systems than 355 
simple, nonhalogenated benzylphosphanes. 356 
The palladated phosphane has an important influence in the catalytic outcome but so far it has not 357 
been possible to rationalise the results of individual catalytic precursors and find clear structure-activity 358 
relationships using simple parameters of the metallated phosphane. This stems from the deficient 359 
knowledge of the nature of the catalytically active species formed from cyclometallated compounds 360 




General Data: All compounds were prepared under a purified nitrogen atmosphere using standard 365 
Schlenk and vacuum-line techniques. The solvents were purified by a solvent purification system or by 366 
standard procedures[33] and kept under nitrogen. Unless otherwise noted, all reagents were purchased 367 
from commercial sources and were used without further purification. Benzyl bromides must be handled 368 
with care, manipulated in an efficient hood, wear protective gloves and eye protection because they may 369 
cause skin, eye and respiratory track irritation. 1H, 13C{1H}, 31P{1H} and 19F NMR spectra were 370 
recorded at room temperature with 250, 300 and 400 MHz spectrometers using CDCl3 as solvent unless 371 
otherwise specified. 1H-1H NOESY spectra were recorded in 500 MHz spectrometers. Chemical shifts 372 
are reported in ppm relative to residual solvent peaks. IR spectra were recorded in KBr and the main 373 
absorption bands are expressed in cm–1. Mass spectrometry (MS) and highresolution mass (HRMS) 374 
analyses were carried out in a time-of-flight instrument using electrospray ionisation. The microanalyses 375 
given are the best that could be obtained. The discrepancies observed are probably due to the presence of 376 
residual solvents (as observed by 1H NMR), which were impossible to remove despite leaving the 377 
complexes under high vacuum for several hours. Gas chromatography analyses of the catalytic runs 378 
were performed using a gas chromatograph, equipped with a FID detector, and a capillary column. 379 
 380 
Synthesis of Phosphane-boranes: To a mixture of 1 mmol of the appropriate benzyl bromide and 1.2 381 
mmol of previously ground magnesium turnings, 5 mL of diethyl ether were added, and the mixture was 382 
stirred at room temperature for 1 h. The reaction was moderately exothermic, and during the formation 383 
of the Grignard reagent, the solution turned to a dark grey colour. The solution was then cooled to 0 °C 384 
and 1 mmol of ClPR2 in 10 mL of diethyl ether were added dropwise. The mixture was stirred for 1 h, 385 
allowing the reaction to warm up to room temperature and 1.5 mL of boranedimethyl sulfide solution (1 386 
M in THF) were added. 10 mL of a degassed solution of 10 % NH4Cl was added and the mixture was 387 
stirred for 30 min to allow hydrolysis of the unreacted magnesium turnings. The diethyl ether was 388 
removed under reduced pressure and the resulting aqueous mixture was washed with dichloromethane (3 389 
× 5 mL). The organic layer was filtered and dried with anhydrous Na2SO4 and the resulting solution 390 
was concentrated to dryness. The crude product was purified as detailed for each comstirred for 30 min 391 
to allow hydrolysis of the unreacted magnesium turnings. The diethyl ether was removed under reduced 392 
pressure and the resulting aqueous mixture was washed with dichloromethane (3 × 5 mL). The organic 393 
layer was filtered and dried with anhydrous Na2SO4 and the resulting solution was concentrated to  394 
dryness. The crude product was purified as detailed for each com pound under vacuum to half its 395 
volume, and absolute ethanol was added until appearance of turbidity. Storing the mixture at –20 °C for 396 
24 h resulted in the precipitation of the phosphane-borane adduct, which was filtered off and dried under 397 
vacuum. 398 
 399 
(2,5-Dichlorobenzyl)diphenylphosphane-borane (1a′): The preparation was carried out according to 400 
the general procedure. The crude product was purified by column chromatography (hexane/ethyl acetate 401 
mixtures) to obtain the phosphane-borane as a colourless resin (0.247 g, 69 % yield). 1H NMR: 3.77 (d, 402 
2H; J = 12.0 Hz, CH2(Bn)); 6.90–7.10 (m, 3H, CH(Ar)); 7.30–7.60 (m, 10H, CH(Ph)). 13C{1H} NMR: 403 
30.8 (d, J = 31.6 Hz, CH2(Bn)); 128.6 (s, CH); 128.8 (d, J = 9.6 Hz, CH); 130.5 (s, CH); 131.7 (s, CH); 404 
131.8 (d, J = 3.2 Hz, CH); 132.2 (m, C); 132.3 (d, J = 3.8 Hz, C); 132.6 (m, C); 132.8 (d, J = 8.9 Hz, 405 
CH); 133.1 (d, J = 5.7 Hz, C). 31P{1H} NMR: 17.9 (d, J = 55.7 Hz). IR: 3084, 3058, 2924, 2395, 2361, 406 
2341 ν(B–H), 1640, 1619, 1431, 1099, 1053, 742, 690. HRMS: 355.0385 [M–3H]+. 407 
 408 
Dicyclohexyl(2,5-dichlorobenzyl)phosphane-borane (1b′): The preparation of this compound was 409 
carried out according to the general procedure and was purified by recrystallisation in 410 
dichloromethane/pentane, affording the phosphane-borane as a white powder (0.181 g, 49 % yield). 1H 411 
NMR (–0.03)-0.80 (br; 3H; J ≈ 10 Hz; BH3); 1.10–1.90 (m; 22 H; CH(Cy) + CH2(Cy)); 3.16 (d; 2H; J = 412 
11.9 Hz; CH2(Bn)); 7.14 (d; 1H; J = 8.7 Hz; CH(Ar)); 7.27 (d; 1H; J = 8.7 Hz; CH(Ar)); 7.52 (m; 1H; 413 
CH(Ar)). 13C{1H} NMR: 24.5 (d, J = 26.8 Hz; CH2(Bn)); 26.0 (s; CH2); 26.9 (m; CH2); 27.0 (d; J = 414 
1.5 Hz; CH2); 27.1 (d; J = 1.9 Hz; CH2); 32.2 (d; J = 30.6 Hz; CH); 128.4 (d; J = 2.3 Hz; CH); 130.5 (d, 415 
J = 1.5 Hz; CH); 132.2 (d, J = 4.5 Hz; C); 132.5 (d, J = 2.3 Hz; CH); 132.7 (d; J = 2.5 Hz; C); 134.1 (d; J 416 
= 3.8 Hz; C). 31P{1H} NMR: 29.7 (m). IR: 3081, 3061, 2927, 2854, 2384, 2375, 2331 ν(B–H), 1465, 417 
1448, 1096, 1038, 893, 817. Anal. Calcd for C19H30BCl2P C 61.49 %, H 8.15 %; found C 61.48 %, H 418 
9.15 %. HRMS: 367.1312 [M–3H]+, 369.1373 [M – H]+. 419 
 420 
(2,5-Dichlorobenzyl)diisopropylphosphane-borane (1c′): The preparation of this compound was 421 
carried out according to the general procedure. The crude product was recrystallised from 422 
dichloromethane/ ethanol to obtain the phosphane-borane as a white powder (0.198 g, 68 % yield). 1H 423 
NMR: 0.00–0.80 (br q; 3H; J ≈ 98 Hz; BH3); 1.06 (dd; 6H; J = 14.0, 7.2 Hz; 2 × CH3(iPr)); 1.11 (dd; 424 
6H; J = 14.4, 7.2 Hz; 2 × CH3(iPr)); 2.01 (dht; 2H; J = 10.0, 7.2 Hz; CH(iPr)); 3.11 (d; 2H; J = 12.0 Hz; 425 
CH2(Bn)); 7.08 (m; 1H; CH(Ar)); 7.20 (m; 1H; CH(Ar)); 7.50 (m; 1H; CH(Ar)). 13C{1H} NMR: 17.2 426 
(d; J = 6.9 Hz; CH3); 22.4 (d; J = 30.6 Hz; CH2(Bn)); 24.3 (d; J = 26.8 Hz; CH); 128.5 (s; CH); 130.6 427 
(s; CH); 132.1 (d; J = 5.4 Hz; C); 132.3 (s; CH); 132.7 (s; C); 133.8 (d; J = 3.8 Hz; C). 31P{1H} NMR: 428 
37.5 (q; J = 58.8 Hz). IR: 3084, 2965, 2930, 2875), 2375, 2355, 2334 ν(B–H), 1471, 1454, 1096, 1038, 429 
884, 820, 803. Anal. Calcd for C13H22BCl2P C 53.66 %, H 7.62 %; found C 51.49 %, H 8.12 %. 430 
HRMS: 287.0688 [M–3H]+, 289.0708 [M – H]+. 431 
 432 
Diphenyl(2,5-difluorobenzyl)phosphane-borane (2a′): The preparation of this compound was carried 433 
out according to the general procedure and was purified by recrystallisation in dichloromethane/pentane, 434 
affording the phosphane-borane as a white powder (0.117 g, 36 % yield). 1H NMR: 0.40–1.30 (br q; 435 
3H; J ≈ 96 Hz; BH3); 3.53 (d; 2H; J = 11.6 Hz; CH2(Bn)); 6.70–6.80 (m; 3H; CH(Ar)); 7.35–7.38 (m; 436 
4H; CH(Ar)); 7.39–7.44 (m; 2H; CH(Ar)); 7.54–7.61 (m; 4H; CH(Ar)). 13C{1H} NMR: 26.8 (d; J = 437 
32.8 Hz; CH2(Bn)); 115.4 (dd; J = 23.8, 8.3 Hz; CH); 116.1 (dd; J = 25.7, 8.9 Hz; CH); 118.4 (d; J = 438 
25.0 Hz; CH); 121.3 (m; C); 128.2 (d; J = 54.1 Hz; C); 128.9 (d; J = 9.6 Hz; CH); 131.6 (s; CH); 132.6 439 
(d; J = 9.0 Hz; CH); 156.9 (d; J = 240.1 Hz; CF); 158.1 (d; J = 242.7 Hz; CF). 31P{1H} NMR: 17.7 (d; J 440 
= 71.6 Hz). 19F NMR: –121.4 (m; 1Fo); –118.6 (m; 1Fm). IR: 3078, 3052, 2962, 2921, 2406, 2398, 441 
2352 ν(B–H), 1637, 1614, 1433, 1096, 1050, 742, 692. Anal. Calcd for C19H18BF2P C 69.97 %, H 442 
5.56 %; found C 68.30 %, H 5.76 %. HRMS: 323.1000 [M–3H]+, 329.0910 [M–(BH3)+(OH)]+. 443 
 444 
Dicyclohexyl(2,5-difluorobenzyl)phosphane-borane (2b′): The preparation of this compound was 445 
carried out according to the general procedure and was purified by recrystallisation in 446 
dichloromethane/pentane, affording the phosphane-borane as a white powder (0.230 g, 68 % yield). 1H 447 
NMR: 0.00–0.80 (br q; 3H; J ≈ 74 Hz; BH3); 1.10–1.90 (m; 22 H; CH(Cy) + CH2(Cy)); 3.00 (d; 2H; J = 448 
11.2 Hz; CH2(Bn)); 6.89 (m; 1H; CH(Ar)); 6.98 (m; 1H; CH(Ar)); 7.13 (m; 1H; CH(Ar)). 13C{1H} 449 
NMR: 20.3 (d; J = 27.5 Hz; CH2(Bn)); 26.0 (m; CH2); 26.8–27.1 (m; 2 × CH2); 32.2 (d; J = 30.6 Hz; 450 
CH); 115.1 (dd; J = 7.64, 22.9 Hz; CH); 116.2 (dd; J = 8.4, 25.2 Hz; CH); 118.8 (d; J = 24.5 Hz; CH); 451 
123.0 (m; C); 156.8 (d; J = 236.0 Hz; CF); 158.3 (d; J = 243.0 Hz; CF). 31P{1H} NMR: 30.0 (d; J = 452 
67.0 Hz). 19F NMR: –123.1 (m; 1Fo); –118.6 (m; 1Fm). IR: 3073, 2927, 2849, 2363, 2337 ν(B–H), 453 
1497, 1451, 1207, 1064, 876, 809. Anal. Calcd for C19H30BF2P C 67.47 %, H 8.94 %; found C 67.19 454 
%, H 9.87 %. HRMS: 335.1903 [M–3H]+. 455 
 456 
(2,5-Difluorobenzyl)diisopropylphosphane-borane (2c′): The preparation of this compound was 457 
carried out according to the general procedure. The crude product was purified by column 458 
chromatography (hexane/ethyl acetate mixtures) to obtain the phosphane- borane as a white powder 459 
(0.157 g, 61 % yield). 1H NMR: 0.00–0.80 (br q; 3H; J ≈ 86 Hz; BH3); 1.15 (dd; 6H; J = 7.2, 1.6 Hz; 460 
CH3(iPr)); 1.19 (dd; 6H; J = 7.2, 1.6 Hz; CH3(iPr)); 2.04 (dht; 2H; J = 10.8, 7.2 Hz; CH(iPr)); 3.03 (d; 461 
2H; J = 11.2 Hz; CH2(Bn)); 6.86–6.94 (m; 1H; CH(Ar)); 6.95–7.20 (m; 1H; CH(Ar)); 7.14–7.20 (m; 462 
1H; CH(Ar)). 13C{1H} NMR: 17.0 (d; J = 4.6 Hz; CH3); 20.3 (d; J = 27.6 Hz; CH2(Bn)); 22.2 (d; J = 463 
31.5 Hz; CH); 115.2 (ddd; J = 3.1, 8.3, 23.8 Hz; CH); 116.3 (ddd; J = 2.3, 9.1, 25.3 Hz; CH); 118.8 (dt; 464 
J = 3.0, 24.5 Hz; CH); 122.8 (m; C); 156.8 (d; J = 240.0 Hz; CF); 158.4 (d; J = 243.0 Hz; CF). 31P{1H} 465 
NMR: 36.1 (q, J = 58.5 Hz). 19F NMR: –122.9 (m; 1Fo); –118.6 (m; 1Fm). IR: 3090, 3070, 2979, 2962, 466 
2936, 2875, 2378, 2346, 2369 ν(B–H), 1503, 1463, 1213, 1192, 1067, 1038, 870, 820. Anal. Calcd for 467 
C13H22BF2P C 60.50 %, H 8.59 %; found C 60.35 %, H 8.80 %. HRMS: 255.1287 [M–3H]+. 468 
 469 
Diphenyl(3,4,5-trifluorobenzyl)phosphane-borane (3a′): The preparation of this compound was 470 
carried out according to the general procedure. The crude product was purified by column 471 
chromatography (hexane/ethyl acetate mixtures) to obtain the phosphane-borane as a white powder 472 
(0.182 g, 53 % yield). 1H NMR: 0.40–1.40 (br q; 3H; J ≈ 112 Hz; BH3); 3.50 (d; 2H; J = 11.6 Hz; 473 
CH2(Bn)); 6.56 (m; 2 × CH(Ar)); 7.40–7.80 (m; 10H; CH(Ph)). 13C{1H} NMR: 17.0 (d; J = 4.6 Hz; 474 
CH3); 20.3 (d; J = 27.6 Hz; CH2(Bn)); 22.2 (d; J = 31.5 Hz; CH); 115.2 (ddd; J = 3.1, 8.3, 23.8 Hz; 475 
CH); 116.3 (ddd; J = 2.3, 9.1, 25.3 Hz; CH); 118.8 (dt; J = 3.0, 24.5 Hz; CH); 122.8 (m; C); 156.8 (d; J 476 
= 240.0 Hz; CF); 158.4 (d; J = 243.0 Hz; CF). 31P{1H} NMR: 17.2 (d; J = 62.9 Hz). 19F NMR: –162.1 477 
(tdd; J = 19.9; 13.2; 5.3 Hz; 1Fp); –134.4 (dd; J = 21.0; 8.5 Hz; 2Fm). IR: 3096, 3058, 2916, 2378, 2343 478 
ν(B–H), 1622, 1532, 1451, 1442, 1349, 1041, 861, 742, 707, 690. Anal. Calcd for C19H17BF3P C 479 
66.32 %, H 4.98 %; found C 65.30 %, H 5.34 %. HRMS: 341.0874 [M–3H]+, 347.0812 [M–480 
(BH3)+(OH)]+. 481 
 482 
Dicyclohexyl(3,4,5-trifluorobenzyl)phosphane-borane (3b′): The preparation of this compound was 483 
carried out according to the general procedure. The crude product was purified by column 484 
chromatography (hexane/ethyl acetate mixtures) to obtain the phosphane-borane as a white powder 485 
(0.085 g, 24 % yield). 1H NMR: 0.00–0.80 (br q; 3H; J ≈ 112 Hz; BH3); 1.10–1.90 (m; 22 H; CH(Cy) + 486 
CH2(Cy)); 2.94 (d; 2H; J = 11.6 Hz; CH2(Bn)); 6.92 (t; 2H; J = 6.8 Hz; CH(Ar)). 13C{1H} NMR: 26.0 487 
(s; CH2); 26.9 (m; 2 × CH2); 27.5 (d; J = 27.6 Hz; CH2(Bn)); 32.0 (d; J = 29.8 Hz; CH2); 114.2 (d; J = 488 
16.9 Hz; CH); 130.3 (m; C); 138.9 (d; J = 254.0 Hz; CF); 151.0 (d; J = 254.0 Hz; CF). 31P{1H} NMR: 489 
27.7 (d, J = 58.8 Hz). 19F NMR: –162.2 (td; J = 21.0, 3.7 Hz; 1Fp); –133.8 (dd; J = 19.9, 7.9 Hz; 2Fm). 490 
IR: 2933, 2857, 2375, 2343 ν(B–H), 1530, 1445, 1035, 870, 797. Anal. Calcd for C19H29BF3P C 64.06 491 
%, H 8.21 %; found C 63.76 %, H 8.94 %. HRMS: 353.1812 [M–3H]+, 711.4023 [2M–H]+. 492 
 493 
Diisopropyl(3,4,5-trifluorobenzyl)phosphane-borane (3c′): The preparation of this compound was 494 
carried out according to the general procedure. The crude product was first subjected to column 495 
chromatography (hexane/ethyl acetate mixtures) and subsequently recrystallized from a mixture of 496 
dichloromethane/heptane to obtain the phosphane-borane as a white powder (0.116 g, 42 % yield). 1H 497 
NMR: 0.00–0.80 (br q; 3H; J ≈ 90.4 Hz; BH3); 1.15 (dd; 6H; J = 7.2, 1.6 Hz; CH3(iPr)); 1.18 (dd; 6H; J 498 
= 7.2, 2.0 Hz; CH3(iPr)); 1.98 (dht; 2H; J = 10.4, 7.2 Hz; CH(iPr)); 2.95 (d; 2H; J = 11.6 Hz; CH2(Bn)); 499 
6.94 (td; 2H; J = 6.8, 1.8 Hz; CH(Ar)). 13C{1H} NMR: 17.1 (s; CH3); 22.0 (d; J = 31.4 Hz; CH2(Bn)); 500 
27.6 (d; J = 26.9 Hz; CH); 114.2 (m; CH); 130.0 (s; C); 138.9 (dt; J = 12.8, 251.0 Hz; CF); 151 (dd; J = 501 
10.9, 251.0 Hz; CF). 31P{1H} NMR: 34.6 (q; J = 51.2 Hz). 19F NMR: –162.3 (td; J = 20.3; 4.1 Hz; 502 
1Fp); –133.8 (dd; J = 19.9; 7.9 Hz; 2Fm). IR: 3078, 3061, 3040, 2962, 2933, 2872, 2375, 2340, 2265 503 
ν(B–H), 1622, 1588, 1535, 1465, 1448, 1349, 1070, 1038, 861. Anal. Calcd for C13H21BF3P C 56.56 504 
%, H 7.67 %; found C 56.00 %, H 8.35 %. HRMS: 273.1193 [M–3H]+. 505 
 506 
Synthesis of Palladium Complexes: Cyclometallated palladium dimeric complexes with a bromide 507 
bridge were obtained by reaction of the corresponding phosphane with Pd(OAc)2 followed by 508 
substitution of acetate by bromide. Only the preparation of 1a/5a/8a is described in detail and the rest of 509 
the complexes were obtained by the same protocol. Due to the easy oxidation of the phosphanes all 510 
operations must be carried out under nitrogen. The final purification of the cyclometallated dimer is 511 




Preparation of Phosphane 1a: To a solution of 0.38 g (1.60 mmol) of 2,5-dichlorobenzyl bromide in 516 
10 mL of diethyl ether 0.045 g (1.80 mmol) of previously ground magnesium turnings were added. The 517 
mixture was stirred at 20 °C for 1 h avoiding any temperature increase. The dark grey solution was 518 
cooled to 0 °C and 0.330 g (1.5 mmol) of ClPPh2 in 5 mL of diethyl ether were added dropwise. The 519 
mixture was stirred for 1 h, allowing the reaction to warm up to room temperature. The solvent was 520 
removed under reduced pressure giving a crude resin, which was dissolved in 10 mL of toluene and 521 
washed with deoxygenated water. The organic layer was separated and dried with anhydrous Na2SO4 522 
and filtered off. The solution of 1a (δP = –12.8 ppm) was used immediately without further purification. 523 
 524 
Preparation of Palladium Complexes 5a and 8a: The obtained phosphane solution was slowly added 525 
over a suspension of palladium acetate 0.314 g (1.40 mmol) and sodium acetate 0.254 g (1.80 mmol) in 526 
10 mL of toluene at room temperature. After 5 min of stirring, the reaction mixture was heated at 80 °C 527 
for 12 h. The disappearance of the free phosphane was monitored by 31P{1H} NMR. The solution was 528 
filtered, and the solvent removed under reduced pressure, giving crude 5a (δP = +48.4 ppm). This crude 529 
and lithium bromide 0.155 g, (1.80 mmol) were dissolved in acetone (10 mL) and stirred for 2 h at room 530 
temperature. The solvent was removed under reduced pressure, the solid dissolved in dichloromethane 531 
(10 mL) and washed several times with water. The organic phase was dried with anhydrous Na2SO4, 532 
filtered and after reducing the volume of dichloromethane, absolute ethanol was added. After several 533 
hours in the freezer the resulting yellow complex 8a was filtered off. The yield of calculated from the 534 
initial Pd(OAc)2: 0.30 g (40 % yield). 1H NMR: 4.09 (d; 4H; J = 11.6 Hz; CH2(Bn)); 6.80–6.90 (m; 4H; 535 
CH(Ar)); 7.30–7.80 (m; 20H; CH(Ph)). 13C{1H} NMR: 43.0 (d; J = 36.8 Hz; CH2(Bn)); 126.8 (s; CH); 536 
128.8 (s; CH); 128.9 (d; J = 5.3 Hz; CH); 129.5 (s; C); 130.0 (s; C); 131.9 (s; CH); 133.4 (d; J = 11.5 537 
Hz; CH); 139.8 (s; C). 31P{1H} NMR: 53.1 (s). IR: 3077, 3055, 2950, 2925, 2847, 1433, 1419, 1381, 538 
1165, 1148, 1123, 1104, 1051. Anal. Calc. for C38H28Br2Cl4P2Pd2 C 43.02 %, H 2.66 %; found C 539 
44.12 % H 2.99 %. HRMS: 525.8080 [(M/2)–2H]+. 540 
 541 
Di-μ-bromo-bis{2-[(dicyclohexylphosphano)methyl]-3,6-dichlorophenyl-C1,P}dipalladium(II) 542 
(8b): The procedure was analogous to that employed for 8a but using 1b. The compound was obtained 543 
as a yellow solid after column chromatography. The yield was calculated relative to the initial 544 
Pd(OAc)2: 0.227 g (30 %). δP(1b) = +2.6 ppm (s), δP(5b) = 65.3 (s), 66.3 (s) ppm; 1:3 ratio. 1H NMR: 545 
0.80–2.60 (m; 44 H; CH(Cy) + CH2(Cy)); 3.31 (d; 4H; J = 10.4 Hz; CH2(Bn)); 6.88 (d; 2H; J = 8.4 Hz; 546 
CH(Ar)); 6.96 (d; 2H; J = 8.7 Hz; CH(Ar)). 13C{1H} NMR: 25.8 (s; CH2); 26.0 (d; J = 13.7 Hz; CH); 547 
26.6 (d; J = 11.5 Hz; CH2); 28.2 (s; CH2); 28.9 (s; CH2); 34.4 (d; J = 34.5 Hz; CH2); 35.3 (d; J = 24.5 548 
Hz; CH2(Bn)); 126.2 (s; CH); 127.3 (d; J = 24.5 Hz; C); 128.7 (s; CH); 139.9 (s; C); 144.4 (d; J = 16.0 549 
Hz; C); 152.9 (s; C). 31P{1H} NMR: 78.7 (s). IR: 3046, 2930, 2850, 2784, 1446, 1419, 1157, 1047, 550 
851, 798. Anal. Calc. for C38H52Br2Cl4P2Pd2 C 42.06 %, H 4.83 %; found C 44.04 %, H 5.01 %. 551 
HRMS: 461.0183 [(M/2) – Br]+; 502.0452 [(M/2) – Br+(CH3CN)]+, 1000.9545 [M–Br]+. 552 
 553 
Di-μ-bromo-bis{2-[(diisopropylphosphano)methyl]-3,6-dichlorophenyl-C1,P}dipalladium(II) (8c): 554 
The procedure was analogous to that employed for 8a but using 1c. The compound was obtained as a 555 
yellow solid after column chromatography. The yield was calculated relative to the initial Pd(OAc)2: 556 
0.168 g (26 %). δP(1c) = +10.1 ppm (s), δP(5c) = 60.2 (s) ppm. 1H NMR: 0.95 (dd; 12H; J = 15.6; 7.2 557 
Hz; CH3(iPr)); 1.46 (dd; 12H; J = 18.4; 7.2 Hz; CH3(iPr)); 2.31 (dht; 4H; J = 9.6; 7.2; Hz; CH(iPr)); 558 
3.33 (d; 4H; J = 10.4 Hz; CH2(Bn)); 6.90 (d; 2H; J = 8.4 Hz; CH(Ar)); 6.96 (d; 2H; J = 8.4 Hz; 559 
CH(Ar)). 13C{1H} NMR: δ: 18.0 (s; CH3); 19.2 (s; CH3); 26.0 (d; J = 25.3 Hz; CH2(Bn)); 33.8 (d; J = 560 
33.7 Hz; CH); 126.5 (s; CH); 127.6 (d; J = 22.9 Hz; C); 128.9 (s; CH); 139.8 (s; C); 144.19 (d; J = 16.9 561 
Hz; C); 152.4 (d; J = 3.8 Hz; C). 31P{1H}: 87.1 (s). IR: 3094, 3041, 2958, 2921, 2894, 2871, 1455, 562 
1413, 1237, 1151, 1053, 1026, 878, 802. Anal. Calc. for C26H36Br2Cl4P2Pd2 C 33.76 %, H 3.92 %; 563 
found C 34.02 %, H 4.15 %. HRMS: 380.9544 [(M/2) – Br]+, 421.9819 [(M/2) – Br+(CH3CN)]+. 564 
 565 
Di-μ-bromo-bis{2-[(diphenylphosphano)methyl]-3,6-difluorophenyl-C1,P}dipalladium(II) (9a): 566 
The procedure was analogous to that employed for 8a but using 2a. The compound was obtained as a 567 
yellow solid. The yield was calculated relative to the initial Pd(OAc)2: 0.480 g (69 %). δP(2a) = –11.5 568 
ppm (d, J = 12.1 Hz), δP(6a) = 57.9 (s), 59.3 (s) ppm; 3:2 ratio. 1H NMR: 3.92 (d; J = 12.0 Hz; 4H; 569 
CH2(Bn)); 6.50–6.60 (m; 4H; CH(Ar)); 7.30–7.75 (m; 20H; CH(Ph)). 13C{1H} NMR: 38.9 (d; J = 36.7 570 
Hz; CH2(Bn)); 112.7 (dd; J = 24.4; 8.3; Hz; CH); 114.6 (dd; J = 32.8; 5.8; Hz; CH); 128.9 (d; J = 10.4 571 
Hz; CH); 129.2 (s; C); 129.7 (s; C); 131.5 (s; C); 131.8 (s; CH); 133.3 (d; J = 11.6 Hz; CH); 154.9 (dd; J 572 
= 244.6; 24.4; Hz; CF); 161.7 (d; J = 236.2 Hz; CF). 31P{1H} NMR: 57.0 (s); 57.9 (s) (ratio 1:3). 19F 573 
NMR:–118.5 (m; 1Fo); –94.9 (m; 1Fm). IR: 3087, 3046, 2959, 2916, 1561, 1451, 1433, 1384, 1111, 574 
1099, 969, 864. Anal . Cal c . for C38H28Br2F4P2Pd2 C 45.86 %, H 2.84 %; found C 45.54 %, H 2.96 575 
%. HRMS: 416.9836 [(M/2) – Br]+. 576 
 577 
Di-μ-bromo-bis{2-[(dicyclohexylphosphano)methyl]-3,6-difluorophenyl-C1,P}dipalladium(II) 578 
(9b): The procedure was analogous to that employed for 8a but using 2b. The compound was obtained 579 
as a yellow solid after column chromatography purification. The yield was calculated relative to the 580 
initial Pd(OAc)2: 0.200 g (28 %). δP(2b) = +2.4 ppm (d, J = 9.5 Hz), δP(6b) = 69.3 (s). 1H NMR: 0.80–581 
2.50 (m; 44 H; CH (Cy)+CH2(Cy)); 3.19 (d; J = 10.2 Hz; 4H; CH2(Bn)); 6.64 (d; J = 5.8 Hz; 2H; 582 
CH(Ar)); 6.66 (d; J = 5.8 Hz; 2H; CH(Ar)). 13C{1H} NMR: 25.8 (s; CH2); 26.1 (d; J = 14.1 Hz; CH); 583 
26.6 (d; J = 10.9 Hz; CH2); 28.1 (s; CH2); 28.8 (s; CH2); 29.8 (d; J = 33.5 Hz; CH2); 35.2 (d; J = 25.0 584 
Hz; CH2(Bn)); 112.0 (dd; J = 9.0; 24.4 Hz; CH); 114.2 (d; J = 7.6; 33.4 Hz; CH); 134.1 (d; J = 14.8 Hz; 585 
C); 138.6 (d; J = 41.8 Hz; C); 154.3 (dd; J = 244.6; 24.4 Hz; CF); 161.8 (d; J = 235.0 Hz; CF). 31P{1H} 586 
NMR: 85.1 (s). 19F NMR: –118.5 (m; 1Fo); –93.9 (bd; J = 19.6 Hz; 1Fm). IR: 3061, 2930, 2852, 1558, 587 
1448, 1218, 977, 855. Anal. Calc. for C38H52Br2F4P2Pd2 C 44.77 %, H 5.14 %; found C 46.02 %; H 588 
5.52 %. HRMS: 429.0777 [(M/2) – Br]+, 470.1043 [(M/2) – Br+(CH3CN)]+. 589 
 590 
Di-μ-bromo-bis{2-[(diisopropylphosphano)methyl]-3,6-difluorophenyl-C1,P}dipalladium(II) (9c): 591 
The procedure was analogous to that employed for 8a but using 2c. The compound was obtained as a 592 
yellow solid. The yield was calculated relative to the initial Pd(OAc)2: 0.120 g (20 %). δP(2c) = +10.6 593 
ppm (d, J = 10.5 Hz), δP(6c) = 78.0 (s). 1H NMR: 1.01 (dd; J = 15.6; 7.2 Hz; 12H; CH3(iPr)); 1.48 (dd; 594 
J = 18.0; 7.2 Hz; 12H; CH3(iPr)); 2.35 (dht; J = 9.2; 7.2 Hz; 4H; CH(iPr)); 3.20 (d; J = 10.4 Hz; 4H; 595 
CH2(Bn)); 6.65 (d; J = 5.6 Hz; 2H; CH(Ar)); 6.67 (d; J = 5.6 Hz; 2H; CH(Ar)). 13C{1H} NMR: 17.9 (s; 596 
CH3); 19.1 (s; CH3); 25.9 (d; J = 25.3 Hz; CH2(Bn)); 29.0 (d; J = 32.9 Hz; CH); 112.4 (dd; J = 24.5; 597 
9.1; Hz; CH); 114.4 (dd; J = 32.9; 7.6; Hz; CH); 134.0 (s; C); 134.1 (s; C); 154.7 (d; J = 242.0 Hz; 598 
CF);162.0 (d; J = 234.0 Hz; CF). 31P NMR: 94.8 (s). 19F NMR: –118.3 (bd; J = 19.5 Hz; 1Fo); –94.8 599 
(d; J = 17.3 Hz; 1Fm). IR: 3061, 2962, 2933, 2895, 2869, 1451, 1207, 971, 849, 806. Anal. Calc. for 600 
C26H36Br2F4P2Pd2 C 36.35 %, H 4.22 %; found C 37.16 %, H 4.42 %. HRMS: 349.0143 [(M/2) – 601 
Br]+, 390.0409 [(M/2) – Br+(CH3CN)]+. 602 
 603 
Di-μ-bromo-bis{2-[(diphenylphosphano)methyl]-4,5,6-trifluorophenyl-C1,P}dipalladium(II) (10a): 604 
The procedure was analogous to that employed for 8a but using 3a. The compound was obtained as a 605 
yellow solid. The yield was calculated relative to the initial Pd(OAc)2: 0.195 g (27 %). The compound 606 
showed low solubility in common organic solvents. δP(3a) = –9.9 ppm (s), δP(7a) = 46.0 (s), 46.1 ppm; 607 
1:9 ratio. 1H NMR: 3.88 (d; 4H; J = 12.0 Hz; CH2(Bn)); 6.72 (m; 2H; J = 7.2 Hz; CH(Ar)); 7.30–7.80 608 
(m; 20H; CH(Ph)). 13C{1H} NMR: 44.1 (d; J = 41.4 Hz; CH2(Bn)); 108.23 (m; CH); 128.9 (m; CH); 609 
131.9 (m; CH); 133.7 (d; J = 11.5 Hz; CH). 31P{1H} NMR: 54.3 (s); 54.4 (s) (ratio 1:9). 19F NMR: –610 
163.4 (t; J = 22.5 Hz; 1Fm); –140.1 (m; 1Fp); –109.8 (d; J = 22.5 Hz; 1Fo). IR: 3083, 3056, 2947, 2927, 611 
2854, 1479, 1432, 1416, 1333, 1040, 821, 745. Anal. Calc. for C38H26Br2F6P2Pd2 C 44.26 %; H 2.54 612 
%; found C 46.77 %, H 3.30 %. HRMS: 1031.2119 [M–Br+2CH3CN], 765.0521 [Pd(PC)P]+. 613 
 614 
Di-μ-bromo-bis{2-[(dicyclohexylphosphano)methyl]-4,5,6-trifluorophenyl-C1,P}dipalladium(II) 615 
(10b): The procedure was analogous to that employed for 8a but using 3b. The compound was obtained 616 
as a yellow solid. The yield was calculated relative to the initial Pd(OAc)2: 0.480 g (65 %). The 617 
compound showed low solubility in common organic solvents. δP(3b) = +2.1 ppm (s), δP(7b) = 65.2 (s). 618 
1H NMR: 1.00–2.45 (m; 44 H; CH(Cy) + CH2(Cy)); 3.19 (d; 4H; J = 10.8 Hz; CH2(Bn)); 6.68 (d; 2H; J 619 
= 6.8 Hz; CH(Ar)); 6.69 (d; 2H; J = 6.8 Hz; CH(Ar)). 13C{1H} NMR: 25.8 (s; CH2); 26.1 (d; J = 14.8 620 
Hz; CH); 26.6 (d; J = 11.6 Hz; CH2); 28.2 (s; CH2); 28.8 (s; CH2); 29.8 (s; CH2); 35.1 (d; J = 25.7 Hz; 621 
CH2(Bn)). 31P{1H} NMR: 82.1 (s). 19F NMR: –163.9 (ddd; J = 23.7; 19.9; 5.3 Hz 1Fm); –140.7 (m; J 622 
= 10.5 Hz; 1Fp); –108.9 (dd; J = 26.7; 6.3; Hz; 1Fo). IR: 3040, 2923, 2850, 2797 ν; 1476; 1412; 1333; 623 
1040; 825. Anal. Calc. for C38H50Br2F6P2Pd2 C 43.25 %, H 4.78 %; found C 43.52 %, H 4.83 %. 624 
HRMS: 447.0684 [(M/2) – Br]+, 488.0951 [(M/2) – Br+(CH3CN)]+. 625 
 626 
Di-μ-bromo-bis{2-[(diisopropylphosphano)methyl]-4,5,6-trifluorophenyl-C1,P}dipalladium(II) 627 
(10c): The procedure was analogous to that employed for 8a but using 3c. The compound was obtained 628 
as a yellow solid. The yield was calculated relative to the initial Pd(OAc)2: 0.215 g (34 %). The 629 
compound showed low solubility in common organic solvents. δP(3c) = +10.6 ppm (s), δP(7c) = 74.4 630 
(s). 1H NMR: 1.00 (dd; 12H; J = 15.2; 6.8 Hz; CH3(iPr)); 1.47 (dd; 12H; J = 18.0; 6.8 Hz; CH3(iPr)); 631 
2.34 (dht; 4H; J = 7.2 Hz; CH(iPr)); 3.20 (d; 4H; J = 11.2 Hz; CH2(Bn)); 6.72 (pt; 2H; J = 8.0 Hz; 632 
CH(Ar)). 13C{1H} NMR: 18.0 (s; CH3); 19.1 (s; CH3); 25.8 (d; J = 20.1 Hz; CH2(Bn)); 29.7 (d; J = 633 
10.1 Hz; CH). 31P{1H} NMR: 91.0 (s). 19F NMR: –163.8 (ddd; J = 22.5; 7.5; 3.8 Hz; 1Fm); –140.6 634 
(dpt; J = 18.0; 8.6 Hz; 1Fp); –109.9 (dd; J = 26.3; 6.4 Hz; 1Fo). IR: 3086, 3038, 2955, 2927, 2865, 1474, 635 
1458, 1410, 1330, 1040, 831, 819. Anal. Calc. for C26H34Br2F6P2Pd2: C 34.89 %, H 3.83 %; found C 636 
35.37 %, H 4.01 %. HRMS: 367.0060 [(M/2) – Br]+, 408.0323 [(M/2) – Br+(CH3CN)]+. 637 
 638 
Di-μ-bromo-bis{2-[(diphenylphosphano)methyl]phenyl-C1,P}-dipalladium(II) (12a): The procedure 639 
was analogous to that employed for 8a but using 4a. The compound was obtained as a brown solid. The 640 
yield was calculated relative to the initial Pd(OAc)2: 0.355 g (55 %). δP(4a) = –10.0 ppm (s), δP(11a) = 641 
51.2 (s). 1H NMR: 3.86 (d; 4H; J = 12.0 Hz; CH2(Bn)); 6.82–7.10 (m, 7H); 7.32–7.45 (m, 12H), 7.69–642 
7.83 (m, 9H). 13C{1H} NMR: 43.4 (d; J = 36.9 Hz; 2CH2(Bn)); 124.0–143.9 (C(Ar), CH(Ar)). 643 
31P{1H} NMR: 55.9 (s), 56.4 (s), (ratio 2:3). IR: 3048, 1570, 1434, 1101, 1018, 737, 584. Anal. Calc. 644 
for C38H32Br2P2Pd2: C 49.44 %, H 3.49 %; found C 48.56 %, H 3.73 %. HRMS: 381.0025 [(M/2) – 645 
Br]+, 422.0289 [(M/2) – Br+(CH3CN)]+. 646 
 647 
Di-μ-bromo-bis{2-[(diisopropylphosphano)methyl]phenyl-C1,P}-dipalladium(II) (12c): The 648 
procedure was analogous to that employed for 8a but using 4c. The compound was obtained as a pale 649 
brown solid. The yield was calculated relative to the initial Pd(OAc)2: 0.103 g (19 %). δP(4c) = 9.9 ppm 650 
(s), δP(11c) = 76.0 (s). 1H NMR: 1.05–1.12 (m; 12H; CH3(iPr)); 1.43–1.51 (m; 12H; CH3(iPr)); 2.17–651 
2.41 (m; 4H; CH(iPr)); 3.11–3.19 (m; 4H; CH2(Bn)); 6.87–7.057 (m; 6H; H(Ar)); 7.46–7.95 (m; 2H; 652 
H(Ar)). 13C{1H} NMR: 18.0 (s; CH3(iPr)); 19.3 (s; CH3(iPr)); 25.6 (d; J = 25.1 Hz; CH(iPr)); 32.6 (d; 653 
J = 32.2 Hz; 2CH2(Bn)); 123.7–152.2 (C, CH Ar). 31P{1H} NMR: 89.7 (s), 91.0 (s), (ratio 1:2). IR: 654 
3058, 2954, 2924, 2865, 1570, 1443, 1385, 1247, 1015, 700, 662, 643. Anal. Calc. for 655 
C26H40Br2P2Pd2: C 39.67 %, H 5.12 %; found C 38.97 %, H 5.28 %. HRMS: 313.0337 [(M/2) – Br]+, 656 
354.0604 [(M/2) – Br+(CH3CN)]+. 657 
 658 
trans-Bromo{2-[(diisopropylphosphano)methyl]-3,6-difluorophenyl-659 
C1,P}(tricyclohexylphosphano)palladium(II) (13c): A solution of 9c (0.150 g; 0.17 mmol) and PCy3 660 
(0.140 g, 0.5 mmol) in 10 mL of toluene was stirred at room temperature for 1 h. After evaporation, the 661 
residue was extracted with 10 mL of dichloromethane and dry ethanol was added. After several hours in 662 
the freezer a yellow solid of 13c was filtered off. Yield: 0.156 g (63 %). 1H NMR: 0.80–2.50 (m; 33H; 663 
CH(Cy) + CH2(Cy)); 0.92 (dd; 6H; J = 13.8; 7.1 Hz; CH3(iPr)); 1.36 (dd; 6H; J = 11.1; 26.9 Hz; 664 
CH3(iPr)); 2.25–2.55 (m; CH(iPr)); 3.20 (d; J = 9.5 Hz; CH2(Bn)); 6.62 (m; CH(Ar)). 31P{1H} NMR 665 
(101.1 MHz; C3D6O), δ(ppm): 23.7 (dd; JPP = 414.0; JPF = 27.3 Hz); 77.5 (d; JPP = 414.0 Hz). IR: 666 
3064, 2924, 2846, 1445, 1387, 1239, 1204, 1178, 849, 806. Anal. Calc. for C31H51BrF2P2Pd: C 52.44 667 
%, H 7.24 %; found C 53.43 %, H 8.08 %. HRMS: 629.7009 [M–Br]+, 669.8999 [M–Br+(CH3CN)]+. 668 
 669 
Preparation of Ionic complexes 14–18: A solution of the suitable palladium complex (0.12 mmol) in 670 
CH2Cl2 (5 mL) was Added, whilst stirring, to a CH2Cl2 (5 mL) suspension of norbornadiene (0.36 671 
mmol) and AgBF4 (0.36 mmol). A precipitate appears immediately. The suspension was stirred for 1 h 672 
in the dark, after which time the solid was filtered through a celite pad. The resulting solution was 673 
concentrated under reduced pressure and pentane was added under strong stirring to prevent the 674 
formation of resin. The yellow ionic complex was isolated by filtration and dried under vacuum. 675 
 676 
[{2-[(Diisopropylphosphano)methyl]-3,6-dichlorophenyl-C1,P}-(1,2,4,5-η4)-2,5-677 
bicyclo[2.2.1]heptadiene]palladium(II) Tetrafluoroborate (14c): The compound was obtained as a 678 
yellow solid. Yield: 0.045 g (34 %). 1H NMR: 1.06 (dd; 6H; J = 16.4; 6.4 Hz; CH3(iPr)); 1.40 (dd; 6H; 679 
J = 18.4; 7.2 Hz; CH3(iPr)); 2.21 (bs; 2H; CH2(nbd)); 2.44 (bs; 2H; CH(iPr)); 3.41 (bs; 2H; CH2(Bn)); 680 
4.10 (bs; 2H; CH(nbd)); 6.98 (d; 1H; J = 8.4 Hz; CH(Ar)); 7.1 (d; 1H; J = 8.4 Hz; CH(Ar)); 7.60–7.80 681 
(m; 4H; CH=CHcis(nbd) + CH=CHtrans(nbd)). 13C{1H} NMR: 17.8 (s; CH3); 19.4 (bs; CH3); 24.9 (d; 682 
J = 22.7 Hz; CH2(Bn)); 32.9 (bs; CH); 129.4 (bs; CH). 31P{1H} NMR: 86.7 (s). IR: 3113, 3084, 3040, 683 
2962, 2927, 2872, 1155, 1117, 1088, 1047, 1032. Anal. Calc. for C20H26BCl2F4PPd C 42.78 %, H 684 
4.67 %; found C 40.26 %, H 4.80 %. HRMS: 382.9549 [M–(nbd)]+, 423.9816 [M–(nbd)+(CH3CN)]+. 685 
 686 
[{2-[(Diisopropylphosphano)methyl]-3,6-difluorophenyl-C1,P}(1,2,4,5-η4)-2,5-687 
bicyclo[2.2.1]heptadiene]palladium(II) Tetrafluoroborate (15c): The compound was obtained as a 688 
yellow solid. Yield: 0.118 g (93 %). 1H NMR: 1.18 (dd; 6H; J = 16.4; 6.8 Hz; CH3(iPr)); 1.35 (dd; 6H; 689 
J = 18.4; 7.2; Hz; CH3(iPr)); 2.26 (d; 1H; J = 8.8 Hz; CHH(nbd)); 2.33 (d; 1H; J = 9.2 Hz; CHH(nbd)); 690 
2.62 (ht; 2H; J = 8.8 Hz; CH(iPr)); 3.31 (d; 2H; J = 10.8 Hz; CH2(Bn)); 4.38 (s; 2H; CH(nbd)); 6.73 (m; 691 
1H; CH(Ar)); 6.85 (m; 1H; CH(Ar)); 7.11 (s; 2H; CH=CHcis(nbd)); 7.57 (s; 2H; CH=CHtrans(nbd)). 692 
13C{1H} NMR: 18.1 (d; J = 1.91 Hz; CH3); 19.5 (s; CH3); 25.9 (d; J = 23.2 Hz; CH2(Bn)); 28.2 (d; J = 693 
34.1 Hz; CH); 54.1 (s; CH2); 78.6 (s; CH); 115.1 (dd; J = 33.4; 7.3 Hz; CH=CHcis(nbd)); 115.6 (dd; J = 694 
24.4; 9.9 Hz; CH=CHcis(nbd)); 116.1 (s; CH); 121.5 (dd; J = 10.3; 7.7 Hz; CH); 135.4 (d; J = 12.9 Hz; 695 
CH=CHtrans(nbd)); 140.5 (d; J = 36.6 Hz; CH=CHtrans(nbd)); 143.5 (s; C); 154.6 (dd; J = 246.6; 23.7 696 
Hz; CF); 161.6 (d; J = 233.0 Hz; CF). 31P{1H} NMR: 92.5 (s). 19F NMR: –152.7 (s; 4F; BF4); –114.6 697 
(bd; J = 18.8 Hz; 1Fo); –108.1 (d; J = 16.2 Hz; 1Fm). IR: 3110, 3079, 2968, 2931, 2869, 1565, 1450, 698 
1314, 1225, 1209, 1086, 1058, 1039, 965, 854, 820, 767, 749, 724. Anal. Calc. for C20H26BF6PPd C 699 




bicyclo[2.2.1]heptadiene]palladium(II) Tetrafluoroborate (16c): The compound was obtained as a 704 
yellow solid. Yield: 0.065 g (54 %). The NMR were recorded in [D6]acetone. 1H NMR: 1.14 (dd; 6H; J 705 
= 15.6; 6.8 Hz; CH3(iPr)); 1.28 (br, CH2(nbd)) 1.40 (dd; 6H; J = 18.0; 7.2; Hz; CH3(iPr)); 2.35–2.48 706 
(m; 2H; CH(iPr)); 3.36 (d; 2H; J = 10.8 Hz; CH2(Bn)); 6.86–7.80 (m, H(Ar)). 13C{1H} NMR: 17.8 (br; 707 
CH3(iPr)); 19.1 (d; J = 2.9 Hz, CH3(iPr)); 25.2 (d; J = 27.2 Hz; CH(iPr)); 31.3 (d; J = 34.6 Hz; 708 
CH2(Bn)); 125.2–149.4 (m, C, CH(Ar)). 31P{1H} NMR: 95.4 (s). 19F NMR: –151.8 (s; 4F; BF4). IR: 709 
2961, 2931, 1524, 1447, 1349, 1017 (ν(BF4)), 884, 812, 745, 647. HRMS: 313.0332 [M–(nbd)]+. 710 
 711 
[{2-[(Diphenylphosphano)methyl]phenyl-C1,P}(1,2,4,5-η4)-2,5-712 
bicyclo[2.2.1]heptadiene]palladium(II) Tetrafluoroborate (17a): The compound was obtained as a 713 
yellow solid after recrystallization in CH2Cl2/Et2O. Yield: 0.044 g (33 %). The NMR were recorded in 714 
[D6]acetone. 1H NMR: 1.91 (s; 2H; CH2(nbd)); 3.56 (s; 2H; 2CH(nbd)); 4.22 (d; 2H; J = 13.2 Hz; 715 
CH2(Bn)); 6.74 (s; 3H; CH=CHcis(nbd) + 1H(Ar)); 6.92 (br, 1H(Ar)), 7.06–7.09 (m; 2H; 716 
CH=CHtrans(nbd)); 7.20 (d, J = 9.6, 1H(Ar)); 7.57–7.61 (m, 4H(Ar)); 7.65–7.69 (m, 3H(Ar)); 7.84–7.89 717 
(m, 4H(Ar)). 13C{1H} NMR: 40.6 (d; J = 39.1 Hz; CH2(Bn)); 50.9 (s; 2CH(nbd)); 75.7 (s; CH2(nbd)); 718 
126.1–146.5 (m, C, CH) 31P{1H} NMR: 56.3 (s). 19F NMR: –151.6 (s; 4F; BF4). IR: 3072, 2956, 719 
1436, 1034 (ν(BF4)), 742, 693. HRMS: 381.0019 [M–(nbd)]+. 720 
 721 
[{2-[(Diphenylphosphano)methyl]-4,5,6-trifluorophenyl-C1,P}-(1,2,4,5-η4)-2,5-722 
bicyclo[2.2.1]heptadiene]palladium(II) Tetrafluoroborate (18a): The compound was obtained as a 723 
light yellow solid. Yield: 0.136 g (92 %). 1H NMR: 2.09 (m; 1H; CHH′(nbd)); 2.20 (d; 1H; J = 9.2 Hz; 724 
CH2(nbd)); 4.15 (d; 2H; J = 13.6 Hz; CH2(Bn)); 4.41 (s; 2H; CH(nbd)); 6.30 (s; 2H; CH=CHcis(nbd)); 725 
6.83 (m; 1H; CH(Ar)); 7.41 (broad; 2H; CH=CHtrans(nbd)); 7.50–7.70 (m; 10H; CH(Ph)). 13C{1H} 726 
NMR: 41.2 (d; J = 35.2 Hz; CH2(Bn)); 54.2 (s; CH2); 76.9 (s; CH); 110.4 (m; CH=CHcis(nbd)); 115.9 727 
(m; CH=CHcis(nbd)); 120.5 (pt; J = 9.1 Hz; CH); 126.2 (d; J = 53.7 Hz; C); 129.0 (m; CH); 130.2 (d; J 728 
= 11.6 Hz; CH= CHtrans(nbd)); 133.1 (d; J = 11.6 Hz; CH=CHtrans(nbd)); 133.4 (d; J = 3.0 Hz; CH); 729 
139.7 (m; C). 31P{1H} NMR: 57.3 (s). 19F NMR: –161.9 (ddd; J = 36.5; 18.8; 6.7 Hz; 1F); –152.7 (s; 730 
4F; BF4); –134.6 (dt; J = 9.6 Hz; 1F); –122.3 (dd; J = 26.8; 7.9 Hz; 1F). IR: 3057, 2961, 2924, 2856 ν; 731 
1475; 1435; 1333; 1101; 1036; 823; 746; 696; 517. Anal. Calc. for C26H21BF7PPd C 50.81 %, H 3.44 732 




bicyclo[2.2.1]heptadiene]palladium(II) Tetrafluoroborate (18b): The compound was obtained as a 737 
light yellow solid. Yield: 0.138 g (92 %). 1H NMR: 1.10–2.00 (m; 22H; CH(Cy)+CH2(Cy)); 2.21 (m; 738 
2H; CH2(nbd)); 3.35 (d; 2H; J = 11.4 Hz; CH2(Bn)); 4.33 (s; CH(nbd)); 6.83 (m; CH(Ar)); 6.95 (m; 2H; 739 
CH=CHcis(nbd)); 7.46 (m; 2H; CH=CHtrans(nbd)). 13C{1H} NMR: 25.7 (s; CH2); 26.4 (m; 740 
CH+CH2); 28.7 (d; J = 3.1 Hz; CH2); 30.1 (s; CH2); 33.6 (d; J = 35.2 Hz; CH2(Bn)); 35.2 (d; J = 22.9 741 
Hz; CH2); 54.3 (s; CH2); 78.2 (s; CH); 109.2 (t; J = 19.1 Hz; CH); 115.2 (s; CH=CHcis(nbd)); 120.6 742 
(pt; J = 9.1 Hz; CH=CHcis(nbd)); 143.6 (s; C). 31P{1H} NMR: 81.3 (s). 19F NMR: –162.6 (ddd; J = 743 
26.7; 26.3; 7.9 Hz; 1F); –151.9 (s; BF4); –134.8 (dt; J = 26.3; 13.2 Hz; 1F); –123.8 (dd; J = 26.7; 6.3 744 
Hz; 1F). IR: 3101, 2927, 2852 ν; 1483; 1332; 1088; 1035; 826. Anal. Calc. for C26H33BF7PPd C 49.83 745 
%, H 5.31 %; found C 49.80 %, H 5.92 %. HRMS: 447.0575 [M–(nbd)]+; 488.0539 [M+(CH3CN)]+. 746 
 747 
[{2-[(Diisopropylphosphano)methyl]-4,5,6-trifluorophenyl-C1,P}(1,2,4,5-η4)-2,5-748 
bicyclo[2.2.1]heptadiene]palladium(II) Tetrafluoroborate (18c): The compound was obtained as a 749 
light yellow solid. Yield: 0.077 g (59 %). 1H NMR: 1.16 (dd; 6H; J = 16.8; 6.8; Hz; CH3(iPr)); 1.32 750 
(dd; 6H; J = 18.0; 7.2; Hz; CH3(iPr)); 2.24–2.33 (m; 2H; CH2(nbd)); 2.57 (dht; 2H; J = 9.2; 7.2 Hz; 751 
CH(iPr)); 3.39 (d; 2H; J = 11.6 Hz; CH2(Bn)); 4.39 (s; 2H; CH(nbd)); 6.92 (pt; 1H; J = 7.6 Hz; 752 
CH(Ar)); 7.06 (m; 2H; CH=CHcis(nbd)); 7.55 (m; 2H; CH=CHtrans(nbd)). 13C{1H} NMR: 18.1 (d; J = 753 
1.91 Hz; CH3); 19.5 (s; CH3); 41.2 (d; J = 37.5 Hz; CH2(Bn)); 28.2 (d; J = 34.1 Hz; CH); 54.1 (s; 754 
CH2); 78.6 (s; CH); 115.9 (s; CH=CHcis(nbd)); 120.5 (pt; J = 9.1 Hz; CH=CHcis(nbd)); 116.1 (s; CH); 755 
121.5 (dd; J = 10.3; 7.7 Hz; CH); 130.1 (d; J = 11.5 Hz; CH= CHtrans(nbd)); 133.0 (d; J = 11.0 Hz; 756 
CH=CHtrans(nbd)); 143.5 (s; C); 154.6 (dd; J = 246.6; 23.7 Hz; CF); 161.6 (d; J = 233.0 Hz; CF). 757 
31P{1H} NMR: 88.7 (s). 19F NMR: –162.2 (ddd; J = 26.8; 9.4; 6.7; Hz; 1F); –152.5 (s; BF4); –134.5 758 
(dt; J = 19.9; 9.4 Hz; 1F); –123.7 (dd; J = 26.7; 9.4 Hz; 1F). IR: 3102, 3047, 2969, 2936, 2875, 1486, 759 
1416, 1394, 1333, 1314, 1087, 1068, 1040. HRMS: 367.0066 [M–(nbd)]+, 408.0324 [M–760 
(nbd)+(CH3CN)]+. 761 
 762 
Procedures of the Catalytic Runs: Two parallel catalytic runs were always performed for each 763 
precursor. A Schlenk flask was charged with cesium carbonate (3.58 g, 11 mmol) and DMF (15 mL) 764 
was added. To this suspension bromobenzene (1.05 mL, 10 mmol) and butyl acrylate (2.15 mL, 15 765 
mmol) were subsequently added and the mixture was warmed up to 130 °C for 15 min. Then the 766 
catalytic palladium precursor (0.01 mmol of mononuclear or 0.005 mmol of dinuclear complexes), 767 
previously dissolved in 5 mL of DMF was rapidly added and an aliquot of approximately 0.1 mL (t = 0) 768 
was taken. Five more aliquots were taken. Each aliquot was passed by a short pad of silica eluting with 769 
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Scheme 1. The Mizoroki-Heck reaction. 859 
 860 
Scheme 2. Synthesis of benzylphosphanes, phosphane-boranes and overall yields of the latter. 861 
 862 
Scheme 3. Preparation of dimeric cyclometallated acetate-bridged complexes (not isolated) and the 863 
isolated bromide-bridged complexes. The overall yields are given for the latter. 864 
 865 
Scheme 4. Mixture of complexes formed by reaction of 2b with palladium acetate. 866 
 867 
Scheme 5. Preparation of mononuclear complex 13c. 868 
 869 
Scheme 6. Preparation of cationic complexes with a norbornadiene ligand. 870 
 871 
Scheme 7. M–H reaction between bromobenzene and butyl acrylate. 872 
 873 
Figure.1 Catalytic precursors for the M–H reaction developed by the groups of Herrmann,[7] Cole–874 
Hamilton[9] and those described in the present work. 875 
 876 
Figure.2 Representation of the molecular structure of phosphane-boranes 2c′ (left) and 3c′ (right), with 877 
ellipsoids shown at 50 % probability level and hydrogen atoms omitted for clarity. Selected distances 878 
[Å] and angles (°): for 2c′ P–C7, 1.842(4), P–C9, 1.807(4), P–C12, 1.862(4), P–B, 1.890(5), C9–P–C7 879 
107.75(18), C7–P–C12 101.9(2), C9–P–C12 105.91(17), C7–P–B 113.8(2), C9–P–B 113.2(3), C12–P–880 
B 113.3(2). For 3c′: P–C7, 1.821(3), P–C9, 1.842(3), P–C12, 1.859(3), P–B, 1.914(4), C9–P–C7 881 
103.03(15), C7–P–C12 104.28(14), C9–P–C12 108.06(15), C7–P–B 110.72(16), C9–P–B 114.83(17), 882 
C12–P–B 114.77(17). 883 
 884 
Figure.3. 31P{1H} NMR spectrum of a mixture of brominated complexes obtained from 2b. 885 
 886 
Figure.4 Figure 4. Molecular views of complexes 12a (left) and 12c (right) with ellipsoids drawn at 50 887 
% probability level and H atoms removed for clarity. Selected distances [Å] and angles (°) for 12a: Pd1–888 
C1 1.996(4); Pd1–Br1 2.5324(5); Pd1–P1 2.1930(11); Br1–Pd1–Br1 86.186(18); Br1–Pd1–C1 97.66 889 
(11); C1–Pd1–P1 82.41(11); P1–Pd1–Br1 93.91(3). For 12c: Pd1–C1 2.0281(18); Pd1–Br1 2.5490(3); 890 
Pd1–P1 2.2007(11); Br1–Pd1–Br1 85.524(9); Br1–Pd1–C1 98.47 (5); C1–Pd1–P1 82.10(6); P1–Pd1–891 
Br1 94.010(15). 892 
 893 
Figure.5 Figure 5. 1H NMR (CDCl3) spectrum of 15c. 894 
 895 
Figure.6 Molecular view of complex 17a with ellipsoids drawn at 50 % probability level. H atoms and 896 
the tetrafluoroborate anion have been removed for clarity. Selected distances [Å] and angles (°): Pd1–P1 897 
2.2561(6); Pd1–C8 2.020(2); Pd1–C1 2.300(2); Pd1–C2 2.275(2); Pd1–C6 2.301(3); Pd1–C7 2.316(2); 898 





































































Table 1. Selected NMR data of benzylphosphanes and their borane adducts. 968 
 969 
 970 
Chemical shifts in ppm, coupling constants in Hz; 31P{1H} (101.1 MHz, 298 K) and 1H (400 MHz, 298 971 
K). Multiplicity and JPB and JHP in parenthesis. [a] Recorded in CDCl3; [b] Recorded in diethyl ether 972 
with an external reference (1 % P(OMe)3 in C6D6); [c] Recorded in toluene with an external reference 973 
(1 % P(OMe)3 in C6D6). 974 
975 
Table 2. Selected NMR data of cyclopalladated complexes 5–12.[a] 976 
 977 
[a] Chemical shifts in ppm, coupling constants in Hz; 31P{1H} (101.1 MHz, 298 K), 1H (400 MHz, 298 978 
K) and 13C{1H} (101 MHz, 298 K). Recorded toluene for X = OAc and in CDCl3 for X = Br. 979 
980 
Table 3. Selected NMR data of cyclopalladated complexes 6b′, 9b′ and 13c.[a] 981 
 982 
 983 
[a] Chemical shifts in ppm, coupling constants in Hz; 31P{1H} (101.1 MHz, 298 K) and 1H (400 MHz, 984 
298 K). 985 
986 
Table 4. Selected NMR data of cationic cyclopalladated complexes.[a] 987 
 988 
 989 
[a] Chemical shifts in ppm, coupling constants in Hz; 31P{1H} (101.1 MHz, 298 K) and 1H (400 MHz, 990 
298 K). 991 
992 
Table 5. M–H coupling reactions catalysed by cyclometallated Pd complexes.[a] 993 
 994 
 995 
a] Reaction conditions: bromobenzene (10 mmol), butyl acrylate (15 mmol), Cs2CO3 (11 mmol), Pd 996 
complex (0.1 % of Pd with respect to bromobenzene) in 20 mL of DMF at 130 °C. [b] Styrene instead of 997 
butyl acrylate was used. 998 
999 
Table 6. M–H reactions of butyl acrylate with 4-bromobenzaldehyde and 4-bromoanisol.[a] 1000 
 1001 
 1002 
[a] Reaction conditions: aryl bromide (10 mmol), butyl acrylate (15 mmol), Cs2CO3 (11 mmol), Pd 1003 
complex (0.1 % of Pd with respect to the aryl bromide) in 20 mL of DMF at 130 °C. 1004 
